The CD8+PD‐1hi T cells in the tumour of NSCLC patients thus might represent the tumour antigen–specific CD8+ T cells released from the immune inhibitory effects of PD‐1‐PD‐L1 interaction. This evidence concerns the gene CD8A and non-small cell lung carcinoma.